Jeffrey Robinson, PhD, is Head of US Medical Affairs at Sandoz, leading medical strategy and scientific engagement across its biosimilar and generic medicines portfolio. He brings more than 25 years of pharmaceutical experience spanning medical affairs, clinical development, and evidence generation, with therapeutic-area expertise in ophthalmology, neurology, and endocrinology. Before joining Sandoz in 2013, he held medical leadership roles at Galderma and Novartis. Dr. Robinson holds a PhD in Chemical Engineering from the Georgia Institute of Technology and a BS in Chemical Engineering from the University of South Carolina.
Speakers